Insiders · Profile

Wallace Owen B.

Chief Scientific Officer at Fulcrum Therapeutics. Filing since 19 Feb 2020. CIK 0001778843

Company
Date
Role
Action
Shares
Amount
Of holding
8 Jul 2020
Chief Scientific Officer
Sold, plan not stated
2,951
$59.02K
2.3%
30 Jun 2020
Chief Scientific Officer
Sold, plan not stated
141
$2.82K
0.1%
28 May 2020
Chief Scientific Officer
Sold, plan not stated
2,232
$44.64K
1.7%
27 May 2020
Chief Scientific Officer
Sold, plan not stated
448
$8.96K
0.4%
26 May 2020
Chief Scientific Officer
Sold, plan not stated
412
$8.24K
0.3%
19 Feb 2020
Chief Scientific Officer
Sold, plan not stated
6,088
$121.76K
4.6%
6 decisions on file.